Bioactive Phytochemicals From Wheat Bran
Launched by UNIVERSITY OF ABERDEEN · Jun 26, 2014
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteers will be healthy males or females and aged between 18 and 55 years who have a documented low (less than 1 portion per week) or high (more than or equal 5 portions per week) consumption of wheat bran and are able to give informed consent.
- Exclusion Criteria:
- • are taking any medicines prescribed by their general practitioner
- • are taking drugs to lower high cholesterol levels or high blood pressure
- • regularly take analgesics, antipyretic or anti-inflammatories
- • regularly take nutritional supplements
- • have taken antibiotics in the last three months
- • have given a large blood donation in last three months
About University Of Aberdeen
The University of Aberdeen, a prestigious institution founded in 1495, is a leading center for research and education in healthcare and clinical sciences. With a commitment to advancing knowledge and improving patient outcomes, the university actively sponsors clinical trials that explore innovative treatments and therapies across various medical fields. Leveraging its interdisciplinary expertise and state-of-the-art facilities, the University of Aberdeen fosters collaborations with healthcare professionals and industry partners to enhance the quality of clinical research and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aberdeen, Aberdeenshire, United Kingdom
Patients applied
Trial Officials
Wendy R Russell, PhD
Principal Investigator
Rowett Institute of Nutrition and Health, University of Aberdeen
Baukje de Roos, PhD
Principal Investigator
Rowett Institute of Nutrition and Health, University of Aberdeen
Garry Duthie, Professor
Principal Investigator
Rowett Institute of Nutrition and Health, University of Aberdeen
Jolene McMonagle, PhD
Principal Investigator
Kellogg Company
Reg Fletcher, PhD
Principal Investigator
Kellogg Company
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials